Managing toxicity of (neo)adjuvant chemotherapy by applying electronic health portal-mediated monitoring and coaching of patient-reported side effects: a prospective randomized trial
Indication
Neoadjuvant, Adjuvant, Observational
Description
E-monitoring of patient reported side effects
Contact
Sponsor
Noordwest Ziekenhuisgroep
Principal Investigator(s)
Drs. Mathijs Hendriks (Noordwest Ziekenhuisgroep)
Prof. dr. Sabine Siesling (IKNL/Universiteit Twente)
Dr. Corina van den Hurk (IKNL)
Study manager
Dr. Manon Hanrath-Komen (Noordwest Ziekenhuisgroep)
Dr. Elise van Leeuwen-Stok (Clinical Study Manager BOOG)